14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today CLVS ranks #15520 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Clovis Oncology Stock Forecast NASDAQ:CLVS

$2.44 (0%)

Volume: 4M

Closed: Jan 19, 2022

Hollow Logo Score: -4.019

Clovis Oncology Stock Forecast

$2.44 (0%)

Volume: 4M

Closed: Jan 19, 2022

Score Hollow Logo -4.019

Clovis Oncology Stock Price (Quote) NASDAQ:CLVS

$2.44 ( 0% ) Wednesday, 19th Jan 2022

Range Low Price High Price Comment
30 days $2.43 $3.32 Wednesday, 19th Jan 2022 CLVS stock ended at $2.44. During the day the stock fluctuated 6.56% from a day low at $2.44 to a day high of $2.60.
90 days $2.43 $4.76
52 weeks $2.43 $11.10

Historical Clovis Oncology prices

Date Open High Low Close Volume
2022-01-19 $2.50 $2.60 $2.44 $2.44 4 280 958
2022-01-18 $2.65 $2.66 $2.43 $2.44 6 216 878
2022-01-14 $2.50 $2.72 $2.45 $2.71 4 862 758
2022-01-13 $2.58 $2.62 $2.50 $2.54 3 865 806
2022-01-12 $2.75 $2.82 $2.58 $2.58 3 165 108
2022-01-11 $2.65 $2.84 $2.63 $2.73 3 869 756
2022-01-10 $2.53 $2.64 $2.46 $2.59 3 981 666
2022-01-07 $2.75 $2.82 $2.55 $2.55 4 802 803
2022-01-06 $2.74 $2.83 $2.63 $2.71 3 046 100
2022-01-05 $2.91 $3.00 $2.67 $2.67 4 090 191
2022-01-04 $3.12 $3.13 $2.90 $2.91 3 344 018
2022-01-03 $2.75 $3.14 $2.75 $3.14 4 318 088
2021-12-31 $2.85 $2.94 $2.69 $2.71 3 930 112
2021-12-30 $2.74 $3.00 $2.71 $2.85 4 614 883
2021-12-29 $2.75 $2.80 $2.66 $2.74 3 828 103
2021-12-28 $2.88 $3.02 $2.77 $2.77 3 398 940
2021-12-27 $3.16 $3.16 $2.86 $2.86 3 864 205
2021-12-23 $3.13 $3.22 $3.05 $3.17 2 821 135
2021-12-22 $3.16 $3.25 $3.13 $3.15 1 982 736
2021-12-21 $3.23 $3.32 $3.13 $3.18 3 382 077
2021-12-20 $3.05 $3.30 $2.99 $3.21 3 375 390
2021-12-17 $2.71 $3.22 $2.71 $3.17 6 630 319
2021-12-16 $2.88 $2.92 $2.72 $2.75 3 612 521
2021-12-15 $2.70 $2.85 $2.58 $2.84 4 450 639
2021-12-14 $2.69 $2.77 $2.63 $2.70 3 267 733
2021-12-13 $2.80 $2.89 $2.62 $2.70 4 227 247
2021-12-10 $2.97 $2.97 $2.76 $2.77 2 847 465
2021-12-09 $3.11 $3.16 $2.91 $2.91 3 799 344
2021-12-08 $3.10 $3.19 $3.00 $3.16 3 144 569
2021-12-07 $2.87 $3.18 $2.86 $3.08 5 675 855
2021-12-06 $2.77 $2.87 $2.71 $2.81 4 111 824
2021-12-03 $3.11 $3.11 $2.75 $2.76 5 394 603
2021-12-02 $3.00 $3.13 $2.97 $3.11 5 099 194
2021-12-01 $3.13 $3.28 $2.93 $2.94 5 170 159
2021-11-30 $3.05 $3.18 $3.02 $3.16 4 358 378
2021-11-29 $3.23 $3.30 $3.06 $3.09 3 675 434
2021-11-26 $3.32 $3.33 $3.14 $3.20 2 873 533
2021-11-24 $3.24 $3.41 $3.15 $3.34 2 738 237
2021-11-23 $3.07 $3.34 $3.04 $3.27 7 002 696
2021-11-22 $3.38 $3.41 $3.11 $3.12 5 450 935
2021-11-19 $3.46 $3.47 $3.34 $3.38 4 237 825
2021-11-18 $3.64 $3.70 $3.39 $3.49 5 574 356
2021-11-17 $3.81 $3.86 $3.61 $3.63 4 356 240
2021-11-16 $3.89 $3.91 $3.78 $3.84 3 286 401
2021-11-15 $3.96 $4.00 $3.87 $3.88 2 813 361
2021-11-12 $3.99 $4.05 $3.90 $3.94 3 484 769
2021-11-11 $4.11 $4.13 $3.95 $3.99 6 535 051
2021-11-10 $4.26 $4.26 $4.09 $4.11 4 002 966
2021-11-09 $4.35 $4.36 $4.24 $4.25 2 216 885
2021-11-08 $4.47 $4.51 $4.33 $4.36 2 167 362

About Clovis Oncology

Clovis Oncology Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. It is developing three product candidates, which include Rociletinib, an oral epidermal growth factor receptor and mutant-selective covalent inhibitor that is under review with the U.S. and E.U. regulatory authorities for the treatment of non-small cell lung cancer; Rucapar... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT